US20160275680A1 - T2 spectral analysis for myelin water imaging - Google Patents

T2 spectral analysis for myelin water imaging Download PDF

Info

Publication number
US20160275680A1
US20160275680A1 US15/166,440 US201615166440A US2016275680A1 US 20160275680 A1 US20160275680 A1 US 20160275680A1 US 201615166440 A US201615166440 A US 201615166440A US 2016275680 A1 US2016275680 A1 US 2016275680A1
Authority
US
United States
Prior art keywords
spectral data
spectral
mwf
water fraction
readable medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US15/166,440
Other versions
US9953418B2 (en
Inventor
Junyu Guo
Wilburn E. Reddick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
St Jude Childrens Research Hospital
Original Assignee
St Jude Childrens Research Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Jude Childrens Research Hospital filed Critical St Jude Childrens Research Hospital
Priority to US15/166,440 priority Critical patent/US9953418B2/en
Assigned to ST. JUDE CHILDREN'S RESEARCH HOSPITAL reassignment ST. JUDE CHILDREN'S RESEARCH HOSPITAL ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GUO, JUNYU, REDDICK, WILBURN E.
Publication of US20160275680A1 publication Critical patent/US20160275680A1/en
Application granted granted Critical
Publication of US9953418B2 publication Critical patent/US9953418B2/en
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00Image analysis
    • G06T7/0002Inspection of images, e.g. flaw detection
    • G06T7/0012Biomedical image inspection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/05Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/055Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves  involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7225Details of analog processing, e.g. isolation amplifier, gain or sensitivity adjustment, filtering, baseline or drift compensation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271Specific aspects of physiological measurement analysis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01RMEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00Arrangements or instruments for measuring magnetic variables
    • G01R33/20Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48NMR imaging systems
    • G01R33/50NMR imaging systems based on the determination of relaxation times, e.g. T1 measurement by IR sequences; T2 measurement by multiple-echo sequences
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T5/00Image enhancement or restoration
    • G06T5/70
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01RMEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00Arrangements or instruments for measuring magnetic variables
    • G01R33/20Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48NMR imaging systems
    • G01R33/483NMR imaging systems with selection of signals or spectra from particular regions of the volume, e.g. in vivo spectroscopy
    • G01R33/4833NMR imaging systems with selection of signals or spectra from particular regions of the volume, e.g. in vivo spectroscopy using spatially selective excitation of the volume of interest, e.g. selecting non-orthogonal or inclined slices
    • G01R33/4835NMR imaging systems with selection of signals or spectra from particular regions of the volume, e.g. in vivo spectroscopy using spatially selective excitation of the volume of interest, e.g. selecting non-orthogonal or inclined slices of multiple slices
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00Indexing scheme for image analysis or image enhancement
    • G06T2207/10Image acquisition modality
    • G06T2207/10072Tomographic images
    • G06T2207/10088Magnetic resonance imaging [MRI]
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00Indexing scheme for image analysis or image enhancement
    • G06T2207/20Special algorithmic details
    • G06T2207/20024Filtering details

Definitions

  • MRI is a diagnostic imaging technique in which image contrasts may be generated. Different image contrasts may be sensitive to different pathologies.
  • Two image contrasts for diagnostic medicine are T 1 contrast and T 2 contrast.
  • T 2 contrast corresponds to the rate at which magnetization disappears perpendicular to the main magnetic field.
  • T 2 contrast is useful in clinical imaging. T 2 contrast is often used to facilitate identification of tumors, tissue affected by stroke and other lesions, pathologies, and other differences between normal and diseased tissue.
  • damaged myelin can be distinguished from undamaged myelin based on differences in the T 2 decay.
  • demyelination impairs the conduction of signal for an affected neuron.
  • demylenation results in bundle migration.
  • Bundle migration refers to the distance between nerve fibers in a nerve bundle.
  • T 2 contrast is typically generated using a spin-echo (SE) or turbo-spin-echo (TSE) sequence.
  • SE spin-echo
  • TSE turbo-spin-echo
  • a single spin-echo is formed through a combination of a 90 degree pulse and a 180 degree pulse.
  • the 90 degree pulse generates signal perpendicular to the main magnetic field and is followed by the 180 degree pulse that refocuses transverse magnetization to form an echo.
  • a purely T 2 weighted spin echo signal may be acquired at a point in time after the 180 degree pulse.
  • the time at which the echo is acquired, the echo time (TE) occurs at a time after the 180 degree pulse that is equal to the spacing between the 90 degree pulse and the 180 degree pulse.
  • TE echo time
  • a T 2 decay curve may be measured using a single-slice multi-echo Carr-Purcell-Meiboom-Gill (CPMG) sequence with nonselective composite refocusing pulses and large z-axis gradient crushers.
  • CPMG Carr-Purcell-Meiboom-Gill
  • SNR signal-to-noise ratio
  • a conventional multi-slice CPMG sequence with slice-selective refocusing pulse may be used.
  • the measured curve deviates from the true T 2 decay curve, which may be pronounced for the first several points.
  • a T 2 preparation spiral imaging sequence is used.
  • this method yielded MWF maps with low resolution and poor image quality.
  • Multi-slice techniques based on T 2 * signal decay have also been proposed to achieve larger volume coverage and shorter acquisition time.
  • high sensitivity to local field inhomogeneity is a limitation of this technique for practical applications since local field gradient along a slice direction can introduce non-exponential signal decay.
  • a signal void region is observed in MWF maps even when high-order shim is performed to minimize field inhomogeneity before data acquisition and the correction of field inhomogeneity is performed in the post-processing.
  • FIG. 1 illustrates a method associated with the spectral analysis of T 2 spectral data.
  • FIG. 2 illustrates an example of a normal nerve bundle and an abnormal nerve bundle.
  • FIG. 3 illustrates an example data acquisition scheme with respect to the spectral analysis of T 2 spectral data.
  • FIG. 4A illustrates example refocusing slice profiles associated with T 2 spectral data acquisition.
  • FIG. 4B illustrates example T 2 decay curves representative of acquired T 2 spectral data.
  • FIG. 5 illustrates graphs associated with a T 2 decay curve and T 2 spectral peaks.
  • FIG. 6A illustrates T 2 decay curves of two adjacent example pixels.
  • FIG. 6B illustrates the smoothing of T 2 spectral data with varying values of the regularization constant, ⁇ .
  • FIG. 7 illustrates example intervals associated with spectral peaks.
  • FIG. 8 illustrates example T 2 sampling points associated with determining myelin water fraction.
  • FIG. 9 illustrates an image associated with a conventional refocusing pulse and an image associated with a refocusing pulse that is three times larger.
  • FIG. 10 illustrates images associated with non-weighted regularized T 2 spectral data and images associated with weighted regularized T 2 spectral data.
  • FIG. 11 illustrates images associated with a healthy brain and images associated with a brain affected by lesions.
  • FIG. 12 illustrates an apparatus configured to perform spectral analysis of T 2 spectral data.
  • references to “one embodiment”, “an embodiment”, “one example”, “an example”, and so on, indicate that the embodiment(s) or example(s) so described may include a particular feature, structure, characteristic, property, element, or limitation, but that not every embodiment or example necessarily includes that particular feature, structure, characteristic, property, element or limitation. Furthermore, repeated use of the phrase “in one embodiment” does not necessarily refer to the same embodiment, though it may.
  • Computer-readable medium refers to a non-transitory medium that stores signals, instructions and/or data.
  • a computer-readable medium may take forms, including, but not limited to, non-volatile media, and volatile media.
  • Non-volatile media may include, for example, optical disks, magnetic disks, and so on.
  • Volatile media may include, for example, semiconductor memories, dynamic memory, and so on.
  • a computer-readable medium may include, but are not limited to, a floppy disk, a flexible disk, a hard disk, a magnetic tape, other magnetic medium, an ASIC, a CD, other optical medium, a RAM, a ROM, a memory chip or card, a memory stick, and other media from which a computer, a processor or other electronic device can read.
  • Logic includes but is not limited to hardware, firmware, software and/or combinations thereof to perform a function(s) or an action(s), and/or to cause a function or action from another logic, method, and/or system.
  • Logic may include a software controlled microprocessor, discrete logic (e.g., application specific integrated circuit (ASIC)), an analog circuit, a digital circuit, a programmed logic device, a memory device containing instructions, and so on.
  • Logic may include a gate(s), a combinations of gates, other circuit components, and so on.
  • ASIC application specific integrated circuit
  • logic may be fully embodied as software. Where multiple logical logics are described, it may be possible in some examples to incorporate the multiple logical logics into one physical logic. Similarly, where a single logical logic is described, it may be possible in some examples to distribute that single logical logic between multiple physical logics.
  • Software includes but is not limited to, one or more computer instructions and/or processor instructions that can be read, interpreted, compiled, and/or executed by a computer and/or processor.
  • Software causes a computer, processor, or other electronic device to perform functions, actions and/or behave in a desired manner.
  • Software may be embodied in various forms including routines, algorithms, modules, methods, threads, and/or programs. In different examples software may be embodied in separate applications and/or code from dynamically linked libraries.
  • software may be implemented in executable and/or loadable forms including, but not limited to, a stand-alone program, an object, a function (local and/or remote), a servelet, an applet, instructions stored in a memory, part of an operating system, and so on.
  • computer-readable and/or executable instructions may be located in one logic and/or distributed between multiple communicating, co-operating, and/or parallel processing logics and thus may be loaded and/or executed in serial, parallel, massively parallel and other manners.
  • Suitable software for implementing various components of example systems and methods described herein may be developed using programming languages and tools (e.g., Java, C, C#, C++, SQL, APIs, SDKs, assembler). Software, whether an entire system or a component of a system, may be embodied as an article of manufacture and maintained or provided as part of a machine-readable medium.
  • programming languages and tools e.g., Java, C, C#, C++, SQL, APIs, SDKs, assembler.
  • Example methods may be better appreciated with reference to flow diagrams. While for purposes of simplicity of explanation, the illustrated methodologies are shown and described as a series of blocks, it is to be appreciated that the methodologies are not limited by the order of the blocks, as some blocks can occur in different orders and/or concurrently with other blocks from that shown and described. Moreover, less than all the illustrated blocks may be required to implement an example methodology. Blocks may be combined or separated into multiple components. Furthermore, additional and/or alternative methodologies can employ additional, not illustrated blocks.
  • Myelin is a major substance of the white matter in human brain. Myelin forms an electrically insulating layer to support and protect the axon of a neuron for the proper functioning of the nervous system. Myelin water is quantified with a multi-interval analysis of a T 2 spectrum from a T 2 decay curve.
  • the intervals in human brain may include (1) myelin water, having a T 2 component with a T 2 range from 15 to 40 ms at 3.0 T; (2) tissue water, having a T 2 component with a T 2 range from 40 to 200 ms; (3) long T 2 tissue water, having a T 2 component with a T 2 range from 200 to 800 ms, and (4) cerebrospinal fluid, having a T 2 component with a T 2 range from 800 to 2000 ms.
  • the ratios of the components to the summation of the components are termed myelin water fraction (MWF), tissue water fraction (TWF), long T 2 tissue water fraction (LWF), and cerebral spinal fluid fraction (CSF).
  • Example apparatus and methods are associated with the spectral analysis of magnetic resonance imaging (MRI) T 2 spectral data associated with myelin. This method is called T 2 SPectrum Analysis using a weighted Regularized Approach and non-loCal mean filter (T 2 SPARC).
  • T 2 SPARC weighted Regularized Approach and non-loCal mean filter
  • a modified multi-slice CPMG sequence is employed with a refocusing slice whose thickness is three times larger than an excitation slice.
  • the size of the refocusing slice is configured with respect to the excitation slice to diminish deviations from the curve.
  • Using a refocusing slice thickness that is three times larger than the excitation slices facilitates achieving a balance between acquisition time and quality of T 2 decay curves.
  • a weighted regularized approach with a large regularization coefficient is used in combination with a non-local mean (NLM) de-noising method to reduce the effect of noise and lessen requirement for the quality of T 2 decay curve.
  • NLM non-local mean
  • FIG. 1 illustrates a method 100 associated with T 2 spectral analysis for myelin water imaging.
  • Method 100 includes, at 110 , accessing T 2 spectral data from an object prepared by a pulse sequence and applied by an MRI apparatus.
  • the object may be a brain.
  • Ten axial brain slices may be acquired over two scans. The slice position of the second scan may be shifted relative to the first scan so that the first scan and the second scan are interleaved. While ten slices and two acquisitions are described, one of ordinary skill in the art will appreciate that a greater and/or lesser number of slices and a great and/or lesser number of scans may be employed.
  • a first portion of the T 2 spectral data is misrepresented due to a portion of the slice not being subject to an adequate refocusing pulse. Deviations in the first portion of the T 2 decay curve have a profound effect on the MWF because MWF is derived from the T 2 spectral data in the first interval from 15 to 40 ms.
  • Using a modified refocusing pulse with a slice thickness three times larger than the excitation pulse facilitates acquiring initial T 2 spectral data with greater accuracy.
  • Method 100 also includes, at 120 , controlling the MRI apparatus to perform a spectral analysis of the T 2 spectral data.
  • the spectral analysis includes uniformly weighting the T 2 spectral data, using a pre-determined regularization constant, and using T 2 spectral component thresholds to define the multiple intervals of myelin water imaging.
  • the spectral analysis of the T 2 spectral data includes, at 121 , decomposing the T 2 spectral data using multi-exponential functions to produce T 2 spectra.
  • the multi-exponential functions may be employed using, for example, a non-negative least squares (NNLS) approach.
  • NLS non-negative least squares
  • the spectral analysis at 120 includes, at 122 , regularizing the T 2 spectral amplitude by applying a regularized constant ⁇ .
  • a regularized constant ⁇ Conventionally, a small regularization constant may be used.
  • a sufficiently large regularized constant, ⁇ , can smoothen the T 2 spectra so adjacent pixels of the T 2 spectral data have similar characteristics.
  • the regularization is uniformly weighted for all spectral amplitudes. However, if T 2 spectrum is logarithmically sampled, the regularization puts more weight on spectral amplitudes that correspond to larger log-spaced time intervals. The logarithmically sampled weighting disparity is further aggravated the larger the regularized constant, ⁇ .
  • the example spectral analysis at 120 includes, at 123 , weighting the multi-exponential functions. Weighting is performed so that in one example the regularization is uniformly weighted for the spectral amplitudes.
  • the multi-exponential functions may be weighted with an element representative of inverse of log-spaced T 2 time intervals. For example, at 123 , an inverse of log-spaced T 2 time interval matrix may be applied to the multi-exponential functions.
  • a plurality of T 2 spectra result from applying weighted regularized multi-exponential functions to the T 2 spectral data.
  • the example spectral analysis 120 includes, at 124 , partitioning the T 2 spectra into intervals by fixed thresholds.
  • the intervals may correspond to MWF, TWF, LWF, and CSF.
  • An individual fraction may correspond to an interval.
  • the intervals may be defined by determining thresholds.
  • the example spectral analysis 120 includes, at 125 , generating at least one parametric map.
  • the ratios of at least one of MW, TW, LW, and CS components to the summation of all components are computed to determine the at least one corresponding to MWF, TWF, LWF, and CSF.
  • the computed value of MWF, TWF, LWF, or CSF for the plurality of pixels may be used to generate the corresponding parametric map.
  • the example spectral analysis at 120 includes, at 126 , denoising the at least one parametric map.
  • the parametric map may be de-noised with a Non Local Mean (NLM) filter.
  • NLM Non Local Mean
  • the NLM filter is applied after the T 2 spectral analysis (e.g., wrNNLS).
  • Method 100 also includes, at 130 , providing the at least one parametric map.
  • FIG. 2 illustrates an example of normal white matter 200 and abnormal white matter 250 .
  • the white matter 200 comprises a plurality of nerve fibers.
  • a nerve fiber 210 has an axon 220 .
  • the axon 220 is an extended fiber of a nerve cell that carries a nerve signal.
  • the axon 220 is surrounded by myelin 230 .
  • the nerve fibers are grouped closely together.
  • abnormal white matter 250 the nerve fibers, such as nerve fiber 260 , are not grouped together. Instead, the nerve fibers are subject to bundle migration, meaning the nerve fibers are moving away from one another.
  • FIG. 3 illustrates an example data acquisition scheme 300 associated with the acquisition of T 2 spectral data.
  • a total of ten brain axial slices from two scans may be acquired using a modified pulse sequence on a 3T scanner using 12-channel head coil.
  • a first scan 310 that includes five axial brain slices 311 , 312 , 313 , 314 , and 315 is performed.
  • a second scan 320 that also includes five axial brains slices 321 , 322 , 323 , 324 , and 325 is performed.
  • the individual brain axial slices of the ten brain axial slices have a slice thickness of 5 mm.
  • the slice position of the second scan 320 is shifted 7.5 mm relative to the first scan 310 to form two interleaved scans of ten consecutive slices with 2.5 mm gap.
  • One of ordinary skill in the art will appreciate that greater and/or lesser number of scans may be employed and that different slice shifts and different slice thicknesses may be employed.
  • the acquisition time for the first scan 310 or the second scan 320 may be 5:29 minutes with a total time of 11 minutes.
  • FIG. 4A illustrates a graph 400 associated with the thickness of refocusing slice profiles.
  • An excitation slice thickness is demarcated by dashed lines 410 and 415 .
  • the excitation slice thickness is 5 mm.
  • a conventional refocusing RF pulse has a conventional refocusing slice profile 420 .
  • This imperfection leads to large deviations of the first several points in T 2 decay curve.
  • the first several points are significant to MWF data since the T 2 spectrum corresponding to myelin water is measured in the first interval from 15-40 ms.
  • a modified refocusing profile 430 increases the slice thickness of the refocusing RF to be larger than the excitation slices demarcated by dashed lines 410 and 415 .
  • the slice thickness of the refocusing RF is larger then the excitation slice, then it may be possible to generate more accurate T 2 spectral data.
  • the increased slice thickness of the modified refocusing profile 430 reduces signal deviations.
  • the slice thickness of the modified refocusing slice profile 430 may be three times larger than an excitation slice thickness.
  • FIG. 4B illustrates a conventional measured T 2 decay curve 460 as compared to a modified T 2 decay curve 470 . Due to intrinsic sensitivity to refocusing imperfections, a conventional measured T 2 decay curve 460 deviates from the modified T 2 decay curve 470 , as illustrated for a first portion 465 of the conventional measured T 2 decay curve 460 . Previous attempts to ameliorate the conventional refocusing profile 420 , as shown in FIG. 4A , have included the addition of constant slice crushers around each refocusing pulse. However, initial values of the first portion 465 of the conventional measured T 2 decay curve 460 were still underestimated.
  • the modified refocusing slice profile 430 leads to a substantially ameliorated T 2 decay curve 470 with a corrected first portion 475 . Accordingly, the first portion 475 of the ameliorated T 2 decay curve 470 yields improved T 2 spectrum corresponding to myelin water measured in the first interval from 15-40 ms. Thus, the modified pulse sequence yields more accurate T 2 spectral amplitude(s) corresponding to myelin water.
  • FIG. 5 illustrates example graphs associated with a T 2 decay curve and T 2 spectral peaks.
  • the T 2 spectral data was acquired from two scans of five axial brain slices acquired using a pulse sequence with a modified refocusing slice profile. The data yields a T 2 decay curve 510 .
  • Spectral peaks 531 , 532 , 533 , and 534 of the spectral graph 530 are determined using spectral analysis 520 .
  • T 2 decay signal, y(t n ), of the T 2 decay curve 510 can be described using a general integral of exponential functions:
  • T 2 the amplitude of the spectral component at relaxation time T 2 .
  • T max maximum T 2 value
  • Equation (4) is in a general matrix form.
  • the T 2 spectrum can be solved from this equation.
  • NLS Non-Negative Least Squares
  • Regularization is used to improve the reliability of the solution. Therefore, a regularized approach (e.g., regularized Non-Negative Least Squares (rNNLS)) is used to solve equation (4) by minimizing:
  • ⁇ 2 represents the Euclidean norm
  • is a regularization constant.
  • is a regularization constant.
  • is used in a typical MWF study to satisfy the constraint of 1.02 ⁇ min 2 ⁇ 2 ⁇ 1.025 ⁇ min 2 where ⁇ min 2 is the minimum misfit of a solution (e.g., an NNLS solution).
  • a smaller ⁇ value has been conventionally used to avoid smoothing of the spectral peaks derived from the measured T 2 decay curve because smoothing was viewed as distorting the T 2 spectral data.
  • the regularized approach has been sensitive to noise. Therefore, conventionally, four averages in acquisition are used to double the SNR. Having to acquire four averages prolongs the total acquisition time to over 25 minutes for a single slice. This may be an unacceptably long acquisition time.
  • the regularized term S T in equation (5) includes the spectral amplitude S and T 2 time interval as shown in equation (3).
  • T 2 spectral data is logarithmically sampled
  • regularization puts more weight on spectral amplitudes that correspond to larger log-spaced time intervals. Therefore, in addition to being regularized, the T 2 spectrum amplitude is weighted to ameliorate the problems caused by using logarithmically spaced T 2 time intervals.
  • the larger the T 2 time interval the less weighting. With a larger ⁇ value, weighting can be applied as follows:
  • W is a weighting matrix and its element is equal to the inverse of log-spaced T 2 time intervals.
  • equation (6) the spectral amplitudes are equally weighted in regularization even with logarithmically spaced T 2 time intervals.
  • a filter may be applied.
  • the filter is a non-local mean (NLM) filter.
  • NLM non-local mean
  • the noise is reduced by averaging a large number of similar pixels regardless of whether they are spatially close or not.
  • the de-noising performance of an NLM filter is designed for the presence of similar image structure in contrast to other classical neighborhood filters such as anisotropic filter and Gaussian filter. Therefore, a NLM filter is suitable to de-noise parametric maps of MWF and TWF since they have a large area with similar pixels.
  • a NLM filter with degree of filtering and radiuses of search and similarity window equal to 10, 5 and 2, respectively was used to improve image quality after all MWF, TWF, LWF and CSF parametric maps were scaled by multiplying 1000.
  • FIG. 6A illustrates T 2 decay curves of two adjacent pixels acquired using an example data acquisition scheme.
  • a first T 2 decay curve 610 corresponds to a first adjacent pixel.
  • a second T 2 decay curve 620 corresponds to a second adjacent pixel.
  • the first and second pixels are located in white matter of the brain and have similar characteristics due to their proximity. Therefore, two adjacent pixels should have approximately the same T 2 spectra despite any differences in the amount of noise to which the adjacent pixels are subjected.
  • FIG. 6B illustrates the smoothing of T 2 spectral data with varying values of the regularization constant, ⁇ .
  • a ⁇ value is determined for the first T 2 decay curve 610 (shown in FIG. 6A ) of the first adjacent pixel and the of a second T 2 decay curve 620 (shown in FIG. 6A ) of the second adjacent pixel.
  • the first T 2 decay curve 610 and the second T 2 decay curve 620 are converted to T 2 spectra using the weighted regularized approach (e.g., wrNNLS) described with respect to FIG. 5 .
  • the weighted regularized approach e.g., wrNNLS
  • the first pixel spectral peak corresponds to a small peak component 631 and a large peak component 632 .
  • the second pixel spectral peak corresponds to a small peak component 638 and a large peak component 639 .
  • the small peak components lead to MWF equal to 0% in one pixel and 9.8% in the other pixel.
  • the un-regularized results show different characteristics.
  • a regularization constant, ⁇ is applied to smooth the T 2 spectra so that adjacent pixels of the T 2 spectral data have similar spectral characteristics.
  • a regularization constant sufficient to achieve a desired uniformity between the T 2 spectra (e.g.,T 2 spectra with 1% deviation) may be applied.
  • a regularization constant sufficient to avoid a threshold difference (e.g., a 1% difference) in a spectral characteristic (e.g., spectral amplitude) between the adjacent pixels may be applied.
  • the first pixel spectral peak corresponds to a small peak component 641 and a large peak component 642 .
  • the second pixel spectral peak corresponds to a small peak component 648 and a large peak component 649 .
  • the regularization constant, ⁇ being equal to 0.1 moves the first spectral peak large component 642 closer to the second spectral peak large component 649 .
  • the first pixel spectral peak and the second pixel spectral peak are also associated with small peak components.
  • is defined to be sufficiently large to smooth the T 2 spectra so that adjacent pixels of the T 2 spectral data have characteristics that differ by less than a threshold amount.
  • p may be defined such that spectral peaks overlap by at least a certain amount (e.g., 85%, 90%, 99%).
  • may be defined to achieve a desired stability of myelin water fraction.
  • FIG. 7 illustrates the spectral components derived from a T 2 decay curve.
  • the peaks correspond to components of the T 2 decay curve.
  • the weighted regularized approach with a predetermined ⁇ value results in spectral components corresponding to myelin water component 710 , tissue water component 720 , long T 2 tissue water component 730 , and cerebrospinal fluid component 740 .
  • the ratios of the components to the summation of the components are termed myelin water fraction (MWF), tissue water fraction (TWF), long T 2 tissue water fraction (LWF), and cerebral spinal fluid fraction (CSF) respectively.
  • MMF myelin water fraction
  • TWF tissue water fraction
  • LWF long T 2 tissue water fraction
  • CSF cerebral spinal fluid fraction
  • FIG. 7 illustrates the boundaries of the spectral components.
  • the first boundary 715 separates the myelin water component 710 and the tissue water component 720 .
  • the second boundary 725 separates the tissue water component 720 and the long T 2 tissue water component 730 .
  • the third boundary 735 separates the long T 2 tissue water component 730 and the cerebrospinal fluid component 740 . Defining the first boundary 715 , the second boundary 725 , and the third boundary 735 determines which T 2 spectral points are used to determine the myelin water component 710 , the tissue water component 720 , the long tissue water component 730 , and the cerebrospinal fluid component 740 .
  • inaccuracies in the first boundary 715 , the second boundary 725 , and the third boundary 735 may vary fractions of the myelin water component 710 , the tissue water component 720 , the long T 2 tissue water component 730 , and/or the cerebrospinal fluid component 740 .
  • FIG. 8 illustrates the variation of average MWF 820 caused by using different numbers of T 2 sampling points 810 .
  • Sampling points 810 corresponded to thresholds closest to the specified myelin water T 2 threshold 40 ms. Therefore, the number of sampling points and a time interval can be used to determine an appropriate boundary between spectral components.
  • T 2 is logarithmically sampled
  • the actual upper T 2 boundary of myelin water varies with the different number of sampling points 810 .
  • the upper T 2 boundary change was consistent with average MWF 820 .
  • the variation of average MWF 820 is caused by using the different number of sampling points 810 .
  • T 2 threshold e.g. 40 ms
  • the actual threshold may vary with the number of sampling points 810 and become relevant to the robustness of the wrNNLS approach when T 2 is logarithmically sampled.
  • the largest change of MWF was 2%.
  • a change of 2% in MWF is significant since the average MWF is 12%.
  • FIG. 9 illustrates an image associated with conventional refocusing pulses and an image associated with a refocusing pulse that is three times larger.
  • Conventional myelin water fraction (MWF) image 900 was generated from a conventional refocusing profile.
  • Modified MWF image 950 was generated from a modified refocusing profile.
  • Conventional MWF image 900 and modified MWF image 950 are illustrated in the same gray scale.
  • MWF in the conventional MWF image 900 is substantially lower than that in the modified MWF image 950 .
  • the average MWF value in a region of interest (ROI) 910 for the conventional MWF image 900 is 5.7%.
  • the average MWF value in a corresponding ROI 960 of the modified MWF image 950 is 11.9%. Therefore, the modified MWF image 950 is more accurate than the conventional MWF image 900 .
  • ROI region of interest
  • FIG. 10 illustrates images associated with non-weighted regularized spectral data and images associated with weighted regularized spectral data.
  • Non-weighted parametric maps 1000 correspond to non-weighted MWF 1010 , non-weighted TWF 1020 , non-weighted LWF 1030 , and non-weighted CSF 1040 .
  • the non-weighted parametric maps underestimate the non-weighted MWF 1010 near the edge of brain. Larger contamination in the non-weighted LWF map 1030 from the non-weighted CSF map 1040 is also visible because spectral amplitudes corresponding to larger T 2 value are overweighed in the regularization when using logarithmically spaced sampling.
  • Weighted parametric maps 1050 correspond to weighted MWF 1060 , weighted TWF 1070 , weighted LWF 1080 , and weighted CSF 1090 .
  • the weighted T 2 SPARC method generated more uniform parametric maps than the non-weighted parametric maps 1000 as shown in FIG. 10 .
  • FIG. 11 illustrates images associated a healthy brain and images associated with a brain having lesions.
  • the healthy parametric maps 1100 correspond to healthy map 1105 , healthy MWF 1110 , healthy TWF 1115 , healthy LWF 1120 , and healthy CSF 1125 .
  • diseased parametric maps 1150 are illustrated.
  • the diseased parametric maps 1150 correspond to diseased map 1155 , diseased MWF 1160 , diseased TWF 1165 , diseased LWF 1170 , and diseased CSF 1175 .
  • the difference in contrast in the diseased parametric maps 1150 to the healthy parametric maps 1100 indicates deviations in the corresponding fraction. For example, in the region of interest indicated by arrow 1161 in diseased MWF 1160 has an MWF of 1.9%. In the region of interest indicated by arrow 1162 in diseased MWF 1160 has an MWF of 4.5%. In the healthy MWF 1110 , the corresponding regions of interest have an MWF of 12.3%. The differences in contrast of the healthy parametric maps 1100 and the diseased parametric maps 1150 make the regions of interest indicated by the arrows visually identifiable.
  • FIG. 12 illustrates an example MRI apparatus 1200 configured with a spectral analysis logic 1285 .
  • the apparatus 1200 includes a basic field magnet(s) 1210 and a basic field magnet supply 1220 .
  • the basic field magnets 1210 would produce a uniform B 0 field.
  • the B 0 field may not be uniform, and may vary over an object being imaged by the MRI apparatus 1200 .
  • MRI apparatus 1200 may include gradient coils 1230 configured to emit gradient magnetic fields like G S , G P and G R .
  • the gradient coils 1230 may be controlled, at least in part, by a gradient coils supply 1240 .
  • MRI apparatus 1200 may also include an RF antenna 1250 that is configured to generate RF pulses and to receive resulting magnetic resonance signals from an object to which the RF pulses are directed. In some examples, how the pulses are generated and how the resulting MR signals are received may be controlled and thus may be selectively adapted during an MRI procedure. In one example, separate RF transmission and reception coils can be employed.
  • the RF antenna 1250 may be controlled, at least in part, by an RF transmission-reception unit 1260 .
  • the gradient coils supply 1240 and the RF transmission-reception unit 1260 may be controlled, at least in part, by a control computer 1270 .
  • the magnetic resonance signals received from the RF antenna 1250 can be employed to generate an image, and thus may be subject to a transformation process like a two dimensional FET that generates pixilated image data.
  • the transformation can be performed by an image computer 1280 or other similar processing device.
  • the spectral analysis logic 1285 is configured to perform the methods described herein.
  • the spectral analysis logic 1285 may include a filter logic to de-noise the pixilated image.
  • the image data may then be shown on a display 1290 . While an MR apparatus 1200 is illustrated, it is to be appreciated that in some examples the spectral analysis of spectral data may be employed with other imaging apparatus and/or methods (e.g., spectroscopy).
  • FIG. 1200 illustrates an example MRI apparatus 1200 that includes various components connected in various ways, it is to be appreciated that other MRI apparatus may include other components connected in other ways.
  • the spectral analysis logic 1285 may be configured with elements of example apparatus described to perform example method described herein.
  • spectral analysis logic 1285 may be permanently and/or removably attached to an MRI apparatus. While spectral analysis logic 1285 is illustrated as a single logic connected to the image computer 1280 , it is to be appreciated that spectral analysis logic 1285 may be distributed between and/or operably connected to other elements of apparatus 1200 . Spectral analysis logic 1285 may execute portions of the methods described herein.
  • the phrase “one or more of, A, B, and C” is employed herein, (e.g., a data store configured to store one or more of, A, B, and C) it is intended to convey the set of possibilities A, B, C, AB, AC, BC, and/or ABC (e.g., the data store may store only A, only B, only C, A&B, A&C, B&C, and/or A&B&C). It is not intended to require one of A, one of B, and one of C.
  • the applicants intend to indicate “at least one of A, at least one of B, and at least one of C”, then the phrasing “at least one of A, at least one of B, and at least one of C” will be employed.

Abstract

Apparatus, methods, and other embodiments associated with the spectral analysis of T2 spectral data are described. One example magnetic resonance imaging (MRI) method includes accessing a data set comprising T2 spectral data associated with a magnetic resonance imaging (MRI) signal received from an object. The method also includes decomposing the T2 spectral data with multi-exponential functions to determine T2 spectra corresponding to the T2 spectral data. The T2 spectra are portioned into a plurality of intervals defined by the T2 spectral data acquired in a predetermined time period.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This Application is a Divisional of U.S. National Entry application Ser. No. 14/359,722 filed on May 21, 2014, which claims priority to International Application number PCT/US12/66935 filed on Nov. 29, 2012, which claims priority to U.S. Provisional Application No. 61/565,578 filed on Dec. 1, 2011. The contents of the above referenced applications are hereby incorporated by reference in their entireties.
  • BACKGROUND
  • MRI is a diagnostic imaging technique in which image contrasts may be generated. Different image contrasts may be sensitive to different pathologies. Two image contrasts for diagnostic medicine are T1 contrast and T2 contrast. T2 contrast corresponds to the rate at which magnetization disappears perpendicular to the main magnetic field. T2 contrast is useful in clinical imaging. T2 contrast is often used to facilitate identification of tumors, tissue affected by stroke and other lesions, pathologies, and other differences between normal and diseased tissue.
  • For example, damaged myelin can be distinguished from undamaged myelin based on differences in the T2 decay. One type of damage to myelin, referred to as demyelination, impairs the conduction of signal for an affected neuron. In addition to causing degradation of a neuron's signal, demylenation results in bundle migration. Bundle migration refers to the distance between nerve fibers in a nerve bundle. Some brain diseases including multiple sclerosis (MS), leukoencephalopathy (LE), are related to loss of myelin water (MW). Myelin water fraction (MWF) can serve as a direct indicator of myelin integrity and provide quantitative measurements of myelin structure and change due to white matter diseases.
  • T2 contrast is typically generated using a spin-echo (SE) or turbo-spin-echo (TSE) sequence. A single spin-echo is formed through a combination of a 90 degree pulse and a 180 degree pulse. The 90 degree pulse generates signal perpendicular to the main magnetic field and is followed by the 180 degree pulse that refocuses transverse magnetization to form an echo. A purely T2 weighted spin echo signal may be acquired at a point in time after the 180 degree pulse. The time at which the echo is acquired, the echo time (TE), occurs at a time after the 180 degree pulse that is equal to the spacing between the 90 degree pulse and the 180 degree pulse.
  • Conventionally, a T2 decay curve may be measured using a single-slice multi-echo Carr-Purcell-Meiboom-Gill (CPMG) sequence with nonselective composite refocusing pulses and large z-axis gradient crushers. However, the single-slice coverage, long acquisition time (e.g., 25 minutes) due to nonselective refocusing pulses, and increasing signal-to-noise ratio (SNR) are obstacles to practical clinical applications. To increase volume coverage, a conventional multi-slice CPMG sequence with slice-selective refocusing pulse may be used. However, due to intrinsic sensitivity to refocusing imperfection, the measured curve deviates from the true T2 decay curve, which may be pronounced for the first several points.
  • In another conventional method, a T2 preparation spiral imaging sequence is used. However, this method yielded MWF maps with low resolution and poor image quality. Multi-slice techniques based on T2* signal decay have also been proposed to achieve larger volume coverage and shorter acquisition time. However, high sensitivity to local field inhomogeneity is a limitation of this technique for practical applications since local field gradient along a slice direction can introduce non-exponential signal decay. Furthermore, a signal void region is observed in MWF maps even when high-order shim is performed to minimize field inhomogeneity before data acquisition and the correction of field inhomogeneity is performed in the post-processing.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The accompanying drawings, which are incorporated in and constitute a part of the specification, illustrate various example systems, methods, and other example embodiments of various aspects of the invention. It will be appreciated that the illustrated element boundaries (e.g., boxes, groups of boxes, or other shapes) in the figures represent one example of the boundaries. One of ordinary skill in the art will appreciate that in some examples one element may be designed as multiple elements or that multiple elements may be designed as one element. In some examples, an element shown as an internal component of another element may be implemented as an external component and vice versa. Furthermore, elements may not be drawn to scale.
  • FIG. 1 illustrates a method associated with the spectral analysis of T2 spectral data.
  • FIG. 2 illustrates an example of a normal nerve bundle and an abnormal nerve bundle.
  • FIG. 3 illustrates an example data acquisition scheme with respect to the spectral analysis of T2 spectral data.
  • FIG. 4A illustrates example refocusing slice profiles associated with T2 spectral data acquisition.
  • FIG. 4B illustrates example T2 decay curves representative of acquired T2 spectral data.
  • FIG. 5 illustrates graphs associated with a T2 decay curve and T2 spectral peaks.
  • FIG. 6A illustrates T2 decay curves of two adjacent example pixels.
  • FIG. 6B illustrates the smoothing of T2 spectral data with varying values of the regularization constant, μ.
  • FIG. 7 illustrates example intervals associated with spectral peaks.
  • FIG. 8 illustrates example T2 sampling points associated with determining myelin water fraction.
  • FIG. 9 illustrates an image associated with a conventional refocusing pulse and an image associated with a refocusing pulse that is three times larger.
  • FIG. 10 illustrates images associated with non-weighted regularized T2 spectral data and images associated with weighted regularized T2 spectral data.
  • FIG. 11 illustrates images associated with a healthy brain and images associated with a brain affected by lesions.
  • FIG. 12 illustrates an apparatus configured to perform spectral analysis of T2 spectral data.
  • DEFINITIONS
  • The following includes definitions of selected terms employed herein. The definitions include various examples and/or forms of components that fall within the scope of a term and that may be used for implementation. The examples are not intended to be limiting. Both singular and plural forms of terms may be within the definitions.
  • References to “one embodiment”, “an embodiment”, “one example”, “an example”, and so on, indicate that the embodiment(s) or example(s) so described may include a particular feature, structure, characteristic, property, element, or limitation, but that not every embodiment or example necessarily includes that particular feature, structure, characteristic, property, element or limitation. Furthermore, repeated use of the phrase “in one embodiment” does not necessarily refer to the same embodiment, though it may.
  • “Computer-readable medium”, as used herein, refers to a non-transitory medium that stores signals, instructions and/or data. A computer-readable medium may take forms, including, but not limited to, non-volatile media, and volatile media. Non-volatile media may include, for example, optical disks, magnetic disks, and so on. Volatile media may include, for example, semiconductor memories, dynamic memory, and so on. Common forms of a computer-readable medium may include, but are not limited to, a floppy disk, a flexible disk, a hard disk, a magnetic tape, other magnetic medium, an ASIC, a CD, other optical medium, a RAM, a ROM, a memory chip or card, a memory stick, and other media from which a computer, a processor or other electronic device can read.
  • “Logic”, as used herein, includes but is not limited to hardware, firmware, software and/or combinations thereof to perform a function(s) or an action(s), and/or to cause a function or action from another logic, method, and/or system. Logic may include a software controlled microprocessor, discrete logic (e.g., application specific integrated circuit (ASIC)), an analog circuit, a digital circuit, a programmed logic device, a memory device containing instructions, and so on. Logic may include a gate(s), a combinations of gates, other circuit components, and so on. In some examples, logic may be fully embodied as software. Where multiple logical logics are described, it may be possible in some examples to incorporate the multiple logical logics into one physical logic. Similarly, where a single logical logic is described, it may be possible in some examples to distribute that single logical logic between multiple physical logics.
  • “Software”, as used herein, includes but is not limited to, one or more computer instructions and/or processor instructions that can be read, interpreted, compiled, and/or executed by a computer and/or processor. Software causes a computer, processor, or other electronic device to perform functions, actions and/or behave in a desired manner. Software may be embodied in various forms including routines, algorithms, modules, methods, threads, and/or programs. In different examples software may be embodied in separate applications and/or code from dynamically linked libraries. In different examples, software may be implemented in executable and/or loadable forms including, but not limited to, a stand-alone program, an object, a function (local and/or remote), a servelet, an applet, instructions stored in a memory, part of an operating system, and so on. In different examples, computer-readable and/or executable instructions may be located in one logic and/or distributed between multiple communicating, co-operating, and/or parallel processing logics and thus may be loaded and/or executed in serial, parallel, massively parallel and other manners.
  • Suitable software for implementing various components of example systems and methods described herein may be developed using programming languages and tools (e.g., Java, C, C#, C++, SQL, APIs, SDKs, assembler). Software, whether an entire system or a component of a system, may be embodied as an article of manufacture and maintained or provided as part of a machine-readable medium.
  • Some portions of the detailed descriptions that follow are presented in terms of algorithms and symbolic representations of operations on data bits within a memory. These algorithmic descriptions and representations are used by those skilled in the art to convey the substance of their work to others. An algorithm, here and generally, is conceived to be a sequence of operations that produce a result. The operations may include physical manipulations of physical quantities. Usually, though not necessarily, the physical quantities take the form of electrical or magnetic signals capable of being stored, transferred, combined, compared, and otherwise manipulated in a logic, and so on. The physical manipulations create a concrete, tangible, useful, real-world result.
  • It has proven convenient at times, principally for reasons of common usage, to refer to these signals as bits, values, elements, symbols, characters, terms, numbers, and so on. It should be borne in mind, however, that these and similar terms are to be associated with the appropriate physical quantities and are merely convenient labels applied to these quantities. Unless specifically stated otherwise, it is appreciated that throughout the description, terms including processing, computing, determining, and so on, refer to actions and processes of a computer system, logic, processor, or similar electronic device that manipulates and transforms data represented as physical (electronic) quantities.
  • Example methods may be better appreciated with reference to flow diagrams. While for purposes of simplicity of explanation, the illustrated methodologies are shown and described as a series of blocks, it is to be appreciated that the methodologies are not limited by the order of the blocks, as some blocks can occur in different orders and/or concurrently with other blocks from that shown and described. Moreover, less than all the illustrated blocks may be required to implement an example methodology. Blocks may be combined or separated into multiple components. Furthermore, additional and/or alternative methodologies can employ additional, not illustrated blocks.
  • DETAILED DESCRIPTION
  • Myelin is a major substance of the white matter in human brain. Myelin forms an electrically insulating layer to support and protect the axon of a neuron for the proper functioning of the nervous system. Myelin water is quantified with a multi-interval analysis of a T2 spectrum from a T2 decay curve. The intervals in human brain may include (1) myelin water, having a T2 component with a T2 range from 15 to 40 ms at 3.0 T; (2) tissue water, having a T2 component with a T2 range from 40 to 200 ms; (3) long T2 tissue water, having a T2 component with a T2 range from 200 to 800 ms, and (4) cerebrospinal fluid, having a T2 component with a T2 range from 800 to 2000 ms. The ratios of the components to the summation of the components are termed myelin water fraction (MWF), tissue water fraction (TWF), long T2 tissue water fraction (LWF), and cerebral spinal fluid fraction (CSF).
  • Example apparatus and methods are associated with the spectral analysis of magnetic resonance imaging (MRI) T2 spectral data associated with myelin. This method is called T2 SPectrum Analysis using a weighted Regularized Approach and non-loCal mean filter (T2SPARC). In one embodiment, a modified multi-slice CPMG sequence is employed with a refocusing slice whose thickness is three times larger than an excitation slice. The size of the refocusing slice is configured with respect to the excitation slice to diminish deviations from the curve. Using a refocusing slice thickness that is three times larger than the excitation slices facilitates achieving a balance between acquisition time and quality of T2 decay curves. Additionally, since SNR affects the quality of MWF maps, in one embodiment, a weighted regularized approach with a large regularization coefficient is used in combination with a non-local mean (NLM) de-noising method to reduce the effect of noise and lessen requirement for the quality of T2 decay curve. While a refocusing slice three times larger than an excitation slice is described, one of ordinary skill in the art will appreciate that other ratios (e.g., 3.1 to 1, 2.9 to 1) between the refocusing slice and the excitation slice may be employed.
  • FIG. 1 illustrates a method 100 associated with T2 spectral analysis for myelin water imaging. Method 100 includes, at 110, accessing T2 spectral data from an object prepared by a pulse sequence and applied by an MRI apparatus. In one embodiment, the object may be a brain. Ten axial brain slices may be acquired over two scans. The slice position of the second scan may be shifted relative to the first scan so that the first scan and the second scan are interleaved. While ten slices and two acquisitions are described, one of ordinary skill in the art will appreciate that a greater and/or lesser number of slices and a great and/or lesser number of scans may be employed.
  • In conventional T2 imaging, a first portion of the T2 spectral data is misrepresented due to a portion of the slice not being subject to an adequate refocusing pulse. Deviations in the first portion of the T2 decay curve have a profound effect on the MWF because MWF is derived from the T2 spectral data in the first interval from 15 to 40 ms. Using a modified refocusing pulse with a slice thickness three times larger than the excitation pulse facilitates acquiring initial T2 spectral data with greater accuracy.
  • Method 100 also includes, at 120, controlling the MRI apparatus to perform a spectral analysis of the T2 spectral data. The spectral analysis includes uniformly weighting the T2 spectral data, using a pre-determined regularization constant, and using T2 spectral component thresholds to define the multiple intervals of myelin water imaging. In one example, the spectral analysis of the T2 spectral data includes, at 121, decomposing the T2 spectral data using multi-exponential functions to produce T2 spectra. The multi-exponential functions may be employed using, for example, a non-negative least squares (NNLS) approach.
  • To improve the reliability of the result of the multi-exponential functions, the spectral analysis at 120, includes, at 122, regularizing the T2 spectral amplitude by applying a regularized constant μ. Conventionally, a small regularization constant may be used. However, a sufficiently large regularized constant, μ, can smoothen the T2 spectra so adjacent pixels of the T2 spectral data have similar characteristics.
  • If the T2 spectrum is uniformly sampled, the regularization is uniformly weighted for all spectral amplitudes. However, if T2 spectrum is logarithmically sampled, the regularization puts more weight on spectral amplitudes that correspond to larger log-spaced time intervals. The logarithmically sampled weighting disparity is further aggravated the larger the regularized constant, μ.
  • To ameliorate the logarithmically sampled weighting disparity, the example spectral analysis at 120 includes, at 123, weighting the multi-exponential functions. Weighting is performed so that in one example the regularization is uniformly weighted for the spectral amplitudes. The multi-exponential functions may be weighted with an element representative of inverse of log-spaced T2 time intervals. For example, at 123, an inverse of log-spaced T2 time interval matrix may be applied to the multi-exponential functions.
  • A plurality of T2 spectra result from applying weighted regularized multi-exponential functions to the T2 spectral data. The example spectral analysis 120 includes, at 124, partitioning the T2 spectra into intervals by fixed thresholds. In different examples, the intervals may correspond to MWF, TWF, LWF, and CSF. An individual fraction may correspond to an interval. In another embodiment, the intervals may be defined by determining thresholds.
  • The example spectral analysis 120 includes, at 125, generating at least one parametric map. For an individual pixel of a plurality of pixels, the ratios of at least one of MW, TW, LW, and CS components to the summation of all components are computed to determine the at least one corresponding to MWF, TWF, LWF, and CSF. The computed value of MWF, TWF, LWF, or CSF for the plurality of pixels may be used to generate the corresponding parametric map.
  • The example spectral analysis at 120 includes, at 126, denoising the at least one parametric map. In one example, the parametric map may be de-noised with a Non Local Mean (NLM) filter. The NLM filter is applied after the T2 spectral analysis (e.g., wrNNLS). Method 100 also includes, at 130, providing the at least one parametric map.
  • The method 100, as illustrated in FIG. 1, may be used to measure myelin water in white matter. FIG. 2 illustrates an example of normal white matter 200 and abnormal white matter 250. The white matter 200 comprises a plurality of nerve fibers. A nerve fiber 210 has an axon 220. The axon 220 is an extended fiber of a nerve cell that carries a nerve signal. The axon 220 is surrounded by myelin 230. In normal white matter 200 the nerve fibers are grouped closely together. In abnormal white matter 250, the nerve fibers, such as nerve fiber 260, are not grouped together. Instead, the nerve fibers are subject to bundle migration, meaning the nerve fibers are moving away from one another.
  • FIG. 3 illustrates an example data acquisition scheme 300 associated with the acquisition of T2 spectral data. In one example, a total of ten brain axial slices from two scans may be acquired using a modified pulse sequence on a 3T scanner using 12-channel head coil. A first scan 310 that includes five axial brain slices 311, 312, 313, 314, and 315 is performed. Subsequently, a second scan 320 that also includes five axial brains slices 321, 322, 323, 324, and 325 is performed. In the example, the individual brain axial slices of the ten brain axial slices have a slice thickness of 5 mm. The slice position of the second scan 320 is shifted 7.5 mm relative to the first scan 310 to form two interleaved scans of ten consecutive slices with 2.5 mm gap. One of ordinary skill in the art will appreciate that greater and/or lesser number of scans may be employed and that different slice shifts and different slice thicknesses may be employed.
  • The imaging protocol for the two scans in the example may include: FOV=220×220 mm; slice thickness=5 mm; acquisition matrix=256×256; 5 slices with 200% slice gap; TEs=10·N, (N=1, 2, 3, . . . , 32); TR=3000 ms; receiver bandwidth=300 Hz/pixel; GRAPPA reduction factor=2 and the reference line=24. In the example, the acquisition time for the first scan 310 or the second scan 320 may be 5:29 minutes with a total time of 11 minutes.
  • FIG. 4A illustrates a graph 400 associated with the thickness of refocusing slice profiles. Once the number of scans and slices is established based on the imaging protocol, a pulse sequence is determined. Imperfections in the conventional refocusing slice profile 420 contribute to flawed T2 spectral data. A modified pulse sequence with a modified refocusing profile 430 reduces signal deviations as compared to conventional refocusing slice profile 420.
  • An excitation slice thickness is demarcated by dashed lines 410 and 415. In one embodiment the excitation slice thickness is 5 mm. A conventional refocusing RF pulse has a conventional refocusing slice profile 420. Specifically, there is a significant amount of excitation slice, demarcated by dashed lines 410 and 415, with a refocusing pulse less than 180°. This imperfection leads to large deviations of the first several points in T2 decay curve. The first several points are significant to MWF data since the T2 spectrum corresponding to myelin water is measured in the first interval from 15-40 ms.
  • A modified refocusing profile 430 increases the slice thickness of the refocusing RF to be larger than the excitation slices demarcated by dashed lines 410 and 415. When the slice thickness of the refocusing RF is larger then the excitation slice, then it may be possible to generate more accurate T2 spectral data. The increased slice thickness of the modified refocusing profile 430 reduces signal deviations. The slice thickness of the modified refocusing slice profile 430 may be three times larger than an excitation slice thickness.
  • FIG. 4B illustrates a conventional measured T2 decay curve 460 as compared to a modified T2 decay curve 470. Due to intrinsic sensitivity to refocusing imperfections, a conventional measured T2 decay curve 460 deviates from the modified T2 decay curve 470, as illustrated for a first portion 465 of the conventional measured T2 decay curve 460. Previous attempts to ameliorate the conventional refocusing profile 420, as shown in FIG. 4A, have included the addition of constant slice crushers around each refocusing pulse. However, initial values of the first portion 465 of the conventional measured T2 decay curve 460 were still underestimated.
  • The modified refocusing slice profile 430 leads to a substantially ameliorated T2 decay curve 470 with a corrected first portion 475. Accordingly, the first portion 475 of the ameliorated T2 decay curve 470 yields improved T2 spectrum corresponding to myelin water measured in the first interval from 15-40 ms. Thus, the modified pulse sequence yields more accurate T2 spectral amplitude(s) corresponding to myelin water.
  • FIG. 5 illustrates example graphs associated with a T2 decay curve and T2 spectral peaks. The T2 spectral data was acquired from two scans of five axial brain slices acquired using a pulse sequence with a modified refocusing slice profile. The data yields a T2 decay curve 510. Spectral peaks 531, 532, 533, and 534 of the spectral graph 530 are determined using spectral analysis 520.
  • T2 decay signal, y(tn), of the T2 decay curve 510, can be described using a general integral of exponential functions:
  • y ( t n ) = 0 T max S ( T 2 ) - t n T 2 T 2 , n = 1 , 2 , , N ( 1 )
  • where tn is the measured time point equal to n·TE, and TE is time of echo; S(T2) is the amplitude of the spectral component at relaxation time T2. The range of T2 is from zeros to maximum T2 value Tmax (e.g., 2 seconds). This integral equation can be discretized as a summation of piecewise amplitude constants over M small ranges of T2:
  • y n = m = 1 N s Tm - t n T 2 m , n = 1 , 2 , , N , ( 2 )
  • where M is the T2 sampling points and

  • STm=SmΔT2m   (3)
  • where ΔT2m is a logarithmic T2 time interval. Equation (4) is in a general matrix form.
  • Y = ES T , E nm = - t n T 2 m ( 4 )
  • The T2 spectrum can be solved from this equation. The T2 spectrum was partitioned into four intervals: myelin water, T2=15-40 ms; tissue water, 40-200 ms; tissue water with long T2 component, 200-800 ms; cerebral spinal fluid, 800-2000 ms.
  • The spectral amplitudes STm are nonnegative. Thus, an approach, for example, Non-Negative Least Squares (NNLS) approach may be used to perform T2 spectrum analysis 520. Regularization is used to improve the reliability of the solution. Therefore, a regularized approach (e.g., regularized Non-Negative Least Squares (rNNLS)) is used to solve equation (4) by minimizing:

  • χ2=min{∥E S T −Y∥ Z +μ∥S T2 }, S T≧0   (5)
  • where ∥·∥2 represents the Euclidean norm, and μ is a regularization constant. The larger the μ value, the more the T2 spectrum is smoothened. Conventionally, a small value of μ is used in a typical MWF study to satisfy the constraint of 1.02χmin 2≦χ2≦1.025χmin 2 where χmin 2 is the minimum misfit of a solution (e.g., an NNLS solution). A smaller μ value has been conventionally used to avoid smoothing of the spectral peaks derived from the measured T2 decay curve because smoothing was viewed as distorting the T2 spectral data. However, due to use of a smaller μ, the regularized approach has been sensitive to noise. Therefore, conventionally, four averages in acquisition are used to double the SNR. Having to acquire four averages prolongs the total acquisition time to over 25 minutes for a single slice. This may be an unacceptably long acquisition time.
  • The regularized term ST in equation (5) includes the spectral amplitude S and T2 time interval as shown in equation (3). When T2 spectral data is logarithmically sampled, regularization puts more weight on spectral amplitudes that correspond to larger log-spaced time intervals. Therefore, in addition to being regularized, the T2 spectrum amplitude is weighted to ameliorate the problems caused by using logarithmically spaced T2 time intervals. The larger the T2 time interval, the less weighting. With a larger μ value, weighting can be applied as follows:
  • χ 2 = min { || E S T - Y || 2 + μ || W S T || 2 } , W m = 1 Δ T 2 m , S T 0 ( 6 )
  • where W is a weighting matrix and its element is equal to the inverse of log-spaced T2 time intervals. Using equation (6), the spectral amplitudes are equally weighted in regularization even with logarithmically spaced T2 time intervals.
  • In one example, after the weighted regularized multi-exponential functions are applied, a filter may be applied. In one embodiment, the filter is a non-local mean (NLM) filter. The noise is reduced by averaging a large number of similar pixels regardless of whether they are spatially close or not. The de-noising performance of an NLM filter is designed for the presence of similar image structure in contrast to other classical neighborhood filters such as anisotropic filter and Gaussian filter. Therefore, a NLM filter is suitable to de-noise parametric maps of MWF and TWF since they have a large area with similar pixels. In one embodiment, a NLM filter with degree of filtering and radiuses of search and similarity window equal to 10, 5 and 2, respectively was used to improve image quality after all MWF, TWF, LWF and CSF parametric maps were scaled by multiplying 1000.
  • FIG. 6A illustrates T2 decay curves of two adjacent pixels acquired using an example data acquisition scheme. A first T2 decay curve 610 corresponds to a first adjacent pixel. A second T2 decay curve 620 corresponds to a second adjacent pixel. The first and second pixels are located in white matter of the brain and have similar characteristics due to their proximity. Therefore, two adjacent pixels should have approximately the same T2 spectra despite any differences in the amount of noise to which the adjacent pixels are subjected.
  • FIG. 6B illustrates the smoothing of T2 spectral data with varying values of the regularization constant, μ. A μ value is determined for the first T2 decay curve 610 (shown in FIG. 6A) of the first adjacent pixel and the of a second T2 decay curve 620 (shown in FIG. 6A) of the second adjacent pixel. The first T2 decay curve 610 and the second T2 decay curve 620 are converted to T2 spectra using the weighted regularized approach (e.g., wrNNLS) described with respect to FIG. 5.
  • The μ=0 graph 630 illustrates the spectral amplitudes of two adjacent pixels. The first pixel spectral peak corresponds to a small peak component 631 and a large peak component 632. Likewise, the second pixel spectral peak corresponds to a small peak component 638 and a large peak component 639. The first spectral peak and the second spectral peak and their components are distinct. Therefore, despite the first pixel and the second pixel being adjacent, without a regularization constant (e.g., μ=0) the first pixel spectral peak and the second pixel spectral peak of the μ=0 graph 630 have different spectral characteristics. The small peak components lead to MWF equal to 0% in one pixel and 9.8% in the other pixel. Thus, despite the proximity of the first adjacent pixel and the second adjacent pixel, the un-regularized results show different characteristics.
  • A regularization constant, μ, is applied to smooth the T2 spectra so that adjacent pixels of the T2 spectral data have similar spectral characteristics. In one example, a regularization constant sufficient to achieve a desired uniformity between the T2 spectra (e.g.,T2 spectra with 1% deviation) may be applied. Alternatively, a regularization constant sufficient to avoid a threshold difference (e.g., a 1% difference) in a spectral characteristic (e.g., spectral amplitude) between the adjacent pixels may be applied. The μ=0.1 graph 640 illustrates the spectral amplitudes of the two adjacent pixels with a μ=0.1 applied by an example weighted regularized approach (e.g., wrNNLS). The first pixel spectral peak corresponds to a small peak component 641 and a large peak component 642. Likewise, the second pixel spectral peak corresponds to a small peak component 648 and a large peak component 649.
  • The regularization constant, μ, being equal to 0.1 moves the first spectral peak large component 642 closer to the second spectral peak large component 649. The first pixel spectral peak and the second pixel spectral peak are also associated with small peak components. The two small peak components 641 and 648 are located near their respective large peak components. The peaks became broader with a small regularization coefficient μ=0.1, but the first pixel spectral peak small component 641 and the second pixel spectral peak small component 648 are distinct.
  • A regularized constant is determined to be sufficiently large to smooth the T2 spectra so that adjacent pixels of the T2 spectral data have similar characteristics. Accordingly, when p is increased to 0.3, as illustrated in the μ=0.3 graph 650, the first pixel spectral peak 652 and the second pixel spectral peak 659 coincide as broad peaks. Furthermore, the small peak components of the first pixel spectral peak and the second pixel spectral peak are subsumed by the broader first pixel spectral peak 652 and the second pixel spectral peak 659. This is indicative of the spectra near white matter and tissue component becoming one broad peak and having at least more similar spectral characteristics.
  • In μ=1.8 graph 660 the first pixel spectral peak 662 and the second pixel spectral peak 669 are approximately the same. Therefore, when μ is increased to 1.8, the MWFs of both pixels were computed equal to 12.7% and 12.1%, respectively. Thus, as the μ value increases, the sensitivity to measurement noise in the weighted regularized approach decreases. Additionally, the T2 spectrum becomes increasingly smoother. The smoothness (fidelity) of spectrum and the sensitivity to noise are compromised to achieve a result indicative of the first adjacent pixel and the second adjacent pixel having more similar characteristics. Therefore, μ is defined to be sufficiently large to smooth the T2 spectra so that adjacent pixels of the T2 spectral data have characteristics that differ by less than a threshold amount. For example, p may be defined such that spectral peaks overlap by at least a certain amount (e.g., 85%, 90%, 99%). In another example, μ may be defined to achieve a desired stability of myelin water fraction.
  • FIG. 7 illustrates the spectral components derived from a T2 decay curve. The peaks correspond to components of the T2 decay curve. Specifically, the weighted regularized approach with a predetermined μ value, results in spectral components corresponding to myelin water component 710, tissue water component 720, long T2 tissue water component 730, and cerebrospinal fluid component 740. The ratios of the components to the summation of the components are termed myelin water fraction (MWF), tissue water fraction (TWF), long T2 tissue water fraction (LWF), and cerebral spinal fluid fraction (CSF) respectively.
  • FIG. 7 illustrates the boundaries of the spectral components. The first boundary 715 separates the myelin water component 710 and the tissue water component 720. The second boundary 725 separates the tissue water component 720 and the long T2 tissue water component 730. The third boundary 735 separates the long T2 tissue water component 730 and the cerebrospinal fluid component 740. Defining the first boundary 715, the second boundary 725, and the third boundary 735 determines which T2 spectral points are used to determine the myelin water component 710, the tissue water component 720, the long tissue water component 730, and the cerebrospinal fluid component 740. Therefore, inaccuracies in the first boundary 715, the second boundary 725, and the third boundary 735 may vary fractions of the myelin water component 710, the tissue water component 720, the long T2 tissue water component 730, and/or the cerebrospinal fluid component 740.
  • FIG. 8 illustrates the variation of average MWF 820 caused by using different numbers of T2 sampling points 810. Sampling points 810 corresponded to thresholds closest to the specified myelin water T2 threshold 40 ms. Therefore, the number of sampling points and a time interval can be used to determine an appropriate boundary between spectral components. When T2 is logarithmically sampled, the actual upper T2 boundary of myelin water varies with the different number of sampling points 810. In one example, the upper T2 boundary change was consistent with average MWF 820. Thus, the variation of average MWF 820 is caused by using the different number of sampling points 810.
  • Even with a specified myelin water T2 threshold (e.g. 40 ms), the actual threshold may vary with the number of sampling points 810 and become relevant to the robustness of the wrNNLS approach when T2 is logarithmically sampled. The largest change of MWF was 2%. A change of 2% in MWF is significant since the average MWF is 12%.
  • FIG. 9 illustrates an image associated with conventional refocusing pulses and an image associated with a refocusing pulse that is three times larger. Conventional myelin water fraction (MWF) image 900 was generated from a conventional refocusing profile. Modified MWF image 950 was generated from a modified refocusing profile. Conventional MWF image 900 and modified MWF image 950 are illustrated in the same gray scale.
  • Conventional MWF image 900 and modified MWF image 950 were generated using the same data processing techniques (e.g., wrNNLS approach with μ=1.8 and M=96) and NLM filter. MWF in the conventional MWF image 900 is substantially lower than that in the modified MWF image 950. The average MWF value in a region of interest (ROI) 910 for the conventional MWF image 900 is 5.7%. The average MWF value in a corresponding ROI 960 of the modified MWF image 950 is 11.9%. Therefore, the modified MWF image 950 is more accurate than the conventional MWF image 900.
  • FIG. 10 illustrates images associated with non-weighted regularized spectral data and images associated with weighted regularized spectral data. Non-weighted parametric maps 1000 correspond to non-weighted MWF 1010, non-weighted TWF 1020, non-weighted LWF 1030, and non-weighted CSF 1040. The non-weighted parametric maps underestimate the non-weighted MWF 1010 near the edge of brain. Larger contamination in the non-weighted LWF map 1030 from the non-weighted CSF map 1040 is also visible because spectral amplitudes corresponding to larger T2 value are overweighed in the regularization when using logarithmically spaced sampling.
  • The underestimation and contamination increased as the regularization constant increased. Accordingly, image quality of the non-weighted parametric maps 1000 was degraded and became unsuitable for assessing lesions in white matter. Weighted parametric maps 1050 correspond to weighted MWF 1060, weighted TWF 1070, weighted LWF 1080, and weighted CSF 1090. The weighted T2SPARC method generated more uniform parametric maps than the non-weighted parametric maps 1000 as shown in FIG. 10.
  • FIG. 11 illustrates images associated a healthy brain and images associated with a brain having lesions. The healthy parametric maps 1100 correspond to healthy map 1105, healthy MWF 1110, healthy TWF 1115, healthy LWF 1120, and healthy CSF 1125. For comparison, diseased parametric maps 1150 are illustrated. The diseased parametric maps 1150 correspond to diseased map 1155, diseased MWF 1160, diseased TWF 1165, diseased LWF 1170, and diseased CSF 1175.
  • The difference in contrast in the diseased parametric maps 1150 to the healthy parametric maps 1100 indicates deviations in the corresponding fraction. For example, in the region of interest indicated by arrow 1161 in diseased MWF 1160 has an MWF of 1.9%. In the region of interest indicated by arrow 1162 in diseased MWF 1160 has an MWF of 4.5%. In the healthy MWF 1110, the corresponding regions of interest have an MWF of 12.3%. The differences in contrast of the healthy parametric maps 1100 and the diseased parametric maps 1150 make the regions of interest indicated by the arrows visually identifiable.
  • FIG. 12 illustrates an example MRI apparatus 1200 configured with a spectral analysis logic 1285. The apparatus 1200 includes a basic field magnet(s) 1210 and a basic field magnet supply 1220. Ideally, the basic field magnets 1210 would produce a uniform B0 field. However, in practice, the B0 field may not be uniform, and may vary over an object being imaged by the MRI apparatus 1200. MRI apparatus 1200 may include gradient coils 1230 configured to emit gradient magnetic fields like GS, GP and GR. The gradient coils 1230 may be controlled, at least in part, by a gradient coils supply 1240.
  • MRI apparatus 1200 may also include an RF antenna 1250 that is configured to generate RF pulses and to receive resulting magnetic resonance signals from an object to which the RF pulses are directed. In some examples, how the pulses are generated and how the resulting MR signals are received may be controlled and thus may be selectively adapted during an MRI procedure. In one example, separate RF transmission and reception coils can be employed. The RF antenna 1250 may be controlled, at least in part, by an RF transmission-reception unit 1260. The gradient coils supply 1240 and the RF transmission-reception unit 1260 may be controlled, at least in part, by a control computer 1270.
  • The magnetic resonance signals received from the RF antenna 1250 can be employed to generate an image, and thus may be subject to a transformation process like a two dimensional FET that generates pixilated image data. The transformation can be performed by an image computer 1280 or other similar processing device. The spectral analysis logic 1285 is configured to perform the methods described herein. The spectral analysis logic 1285 may include a filter logic to de-noise the pixilated image. The image data may then be shown on a display 1290. While an MR apparatus 1200 is illustrated, it is to be appreciated that in some examples the spectral analysis of spectral data may be employed with other imaging apparatus and/or methods (e.g., spectroscopy).
  • While FIG. 1200 illustrates an example MRI apparatus 1200 that includes various components connected in various ways, it is to be appreciated that other MRI apparatus may include other components connected in other ways. The spectral analysis logic 1285 may be configured with elements of example apparatus described to perform example method described herein.
  • In different examples, spectral analysis logic 1285 may be permanently and/or removably attached to an MRI apparatus. While spectral analysis logic 1285 is illustrated as a single logic connected to the image computer 1280, it is to be appreciated that spectral analysis logic 1285 may be distributed between and/or operably connected to other elements of apparatus 1200. Spectral analysis logic 1285 may execute portions of the methods described herein.
  • To the extent that the term “or” is employed in the detailed description or claims (e.g., A or B) it is intended to mean “A or B or both”. The term “and/or” is used in the same manner, meaning “A or B or both”. When the applicants intend to indicate “only A or B but not both” then the term “only A or B but not both” will be employed. Thus, use of the term “or” herein is the inclusive, and not the exclusive use. See, Bryan A. Garner, A Dictionary of Modern Legal Usage 624 (2d. Ed. 1995).
  • To the extent that the phrase “one or more of, A, B, and C” is employed herein, (e.g., a data store configured to store one or more of, A, B, and C) it is intended to convey the set of possibilities A, B, C, AB, AC, BC, and/or ABC (e.g., the data store may store only A, only B, only C, A&B, A&C, B&C, and/or A&B&C). It is not intended to require one of A, one of B, and one of C. When the applicants intend to indicate “at least one of A, at least one of B, and at least one of C”, then the phrasing “at least one of A, at least one of B, and at least one of C” will be employed.

Claims (20)

What is claimed is:
1. A non-transitory computer-readable medium storing computer-executable instruction that when executed by a computer control the computer to perform a method, the method comprising:
accessing a data set comprising T2 spectral data associated with a magnetic resonance imaging (MRI) signal received from an object;
decomposing the T2 spectral data with multi-exponential functions to determine T2 spectra corresponding to the T2 spectral data; and
partitioning the T2 spectra into a plurality of intervals defined by the T2 spectral data acquired in a predetermined time period.
2. The non-transitory computer readable medium of claim 1, wherein decomposing the T2 spectral data includes regularizing the multi-exponential functions by applying a regularized constant to the T2 spectral data.
3. The non-transitory computer readable medium of claim 2, wherein the regularized constant is sufficiently large to smooth the T2 spectra so adjacent pixels of the T2 spectral data are similar to within a threshold amount.
4. The non-transitory computer readable medium of claim 1, wherein an interval of the plurality of intervals corresponds to at least one of myelin water fraction (MWF), tissue water fraction (TWF), long T2 water fraction (LWF), and cerebrospinal fluid fraction (CSF).
5. The non-transitory computer readable medium of claim 1, comprising weighting the multi-exponential functions with inverse of log-spaced T2 time interval matrix.
6. The non-transitory computer readable medium of claim 1, the method further comprising generating at least one parametric map to correspond to at least one interval.
7. The non-transitory computer readable medium of claim 6, wherein the at least one parametric map has intervals associated with myelin water fraction (MWF), tissue water fraction (TWF), long T2 water fraction (LWF), and cerebrospinal fluid fraction (CSF).
8. The non-transitory computer readable medium of claim 6, the method further comprising de-noising the at least one parametric map and providing the denoised parametric map.
9. The non-transitory computer readable medium of claim 8, wherein the parametric map is denoised with a non-local mean (NLM) filter.
10. A method comprising:
accessing a data set comprising T2 spectral data associated with a magnetic resonance imaging (MR) signal received from an object;
decomposing the T2 spectral data with an integral using multi-exponential functions to determine T2 spectra, wherein the multi-exponential functions are regularized by applying a regularized constant to the T2 spectral data; and
partitioning the T2 spectra into intervals by determining thresholds, a threshold is defined by the T2 spectral data acquired in a predetermined time period, and wherein an interval corresponds to an individual spectrum.
11. The method of claim 10, the method further comprising weighting the T2 spectral data so that the regularization is weighted to within a desired uniformity for spectral amplitudes.
12. The method of claim 10, wherein an inverse of log-spaced T2 time interval matrix is applied to the T2 spectral data.
13. The method of claim 10, the method further comprising generating at least one parametric map to correspond to at least one interval.
14. The method of claim 13, wherein the at least one parametric map corresponds to at least one of myelin water fraction (MWF), tissue water fraction (TWF), long T2 water fraction (LWF), and cerebrospinal fluid fraction (CSF).
15. The method of claim 13, the method further comprising de-noising the at least one parametric map and providing the denoised parametric map.
16. An apparatus, comprising;
a processor;
a memory configured to store a set of T2 spectral data associated with magnetic resonance imaging (MRI) signal received from an object; and
a spectral analysis logic configured to decompose the T2 spectral data with weighted regularized multi-exponential functions, and to generate at least one parametric map based, at least in part on the T2 spectral data, wherein the spectral logic is further configured to regularize the multi-exponential functions by applying a regularized constant to the T2 spectral data.
17. The apparatus of claim 16, comprising a filter logic configured to de-noise the at least one parametric map using a non-local mean (NLM) filter.
18. The apparatus of claim 16, wherein the spectral analysis logic is configured to partition T2 spectra resulting from the T2 spectral data into a plurality of intervals by determining thresholds, wherein a threshold is defined by the T2 spectral data acquired in a predetermined time.
19. The apparatus of claim 18, wherein an interval of the plurality of intervals corresponds to at least one of myelin water fraction (MWF), tissue water fraction (TWF), long T2 water fraction (LWF), and cerebrospinal fluid fraction (CSF).
20. The apparatus of claim 16, wherein the regularized constant is sufficiently large to smooth the T2 spectra so adjacent pixels of the T2 spectral data are similar to within a threshold amount.
US15/166,440 2011-12-01 2016-05-27 T2 spectral analysis for myelin water imaging Active 2033-01-30 US9953418B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US15/166,440 US9953418B2 (en) 2011-12-01 2016-05-27 T2 spectral analysis for myelin water imaging

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161565578P 2011-12-01 2011-12-01
PCT/US2012/066935 WO2013082207A1 (en) 2011-12-01 2012-11-29 T2 spectral analysis for myelin water imaging
US201414359722A 2014-05-21 2014-05-21
US15/166,440 US9953418B2 (en) 2011-12-01 2016-05-27 T2 spectral analysis for myelin water imaging

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US14/359,722 Division US9378548B2 (en) 2011-12-01 2012-11-29 T2 spectral analysis for myelin water imaging
PCT/US2012/066935 Division WO2013082207A1 (en) 2011-12-01 2012-11-29 T2 spectral analysis for myelin water imaging

Publications (2)

Publication Number Publication Date
US20160275680A1 true US20160275680A1 (en) 2016-09-22
US9953418B2 US9953418B2 (en) 2018-04-24

Family

ID=48536030

Family Applications (2)

Application Number Title Priority Date Filing Date
US14/359,722 Active 2033-05-01 US9378548B2 (en) 2011-12-01 2012-11-29 T2 spectral analysis for myelin water imaging
US15/166,440 Active 2033-01-30 US9953418B2 (en) 2011-12-01 2016-05-27 T2 spectral analysis for myelin water imaging

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US14/359,722 Active 2033-05-01 US9378548B2 (en) 2011-12-01 2012-11-29 T2 spectral analysis for myelin water imaging

Country Status (2)

Country Link
US (2) US9378548B2 (en)
WO (1) WO2013082207A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130176026A1 (en) * 2012-01-11 2013-07-11 Schlumberger Technology Corporation Magnetic Resonance Imaging Methods

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014085384A1 (en) * 2012-11-30 2014-06-05 The Trustees Of The University Of Pennsylvania Background-suppressed myelin water imaging
CN105518477B (en) * 2013-09-05 2019-08-20 皇家飞利浦有限公司 Use space adaptive regularization is with the MRI for image reconstruction
US9852353B2 (en) * 2014-11-12 2017-12-26 Adobe Systems Incorporated Structure aware image denoising and noise variance estimation
US10096109B1 (en) * 2017-03-31 2018-10-09 The Board Of Trustees Of The Leland Stanford Junior University Quality of medical images using multi-contrast and deep learning
KR20200063222A (en) * 2017-10-09 2020-06-04 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 Contrast dose reduction in medical imaging with deep learning
DE102019207558A1 (en) 2019-05-23 2020-11-26 Siemens Healthcare Gmbh Method for recording magnetic resonance data, magnetic resonance devices, computer programs and electronically readable data carriers
CN114096991A (en) 2019-06-03 2022-02-25 梅鲁诺娃有限公司 MRI post-processing system and method
JP2023027425A (en) * 2021-08-17 2023-03-02 キヤノンメディカルシステムズ株式会社 Magnetic resonance imaging device

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080292194A1 (en) * 2005-04-27 2008-11-27 Mark Schmidt Method and System for Automatic Detection and Segmentation of Tumors and Associated Edema (Swelling) in Magnetic Resonance (Mri) Images
US20120280686A1 (en) * 2011-05-06 2012-11-08 The Regents Of The University Of California Measuring biological tissue parameters using diffusion magnetic resonance imaging

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8170644B2 (en) * 2006-04-18 2012-05-01 The Regents Of The University Of Colorado Method for fast multi-slice mapping of myelin water fraction
WO2008144421A1 (en) * 2007-05-17 2008-11-27 University Of Washington Fast two-point mapping of the bound pool fraction and cross-relaxation rate constant for mri

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080292194A1 (en) * 2005-04-27 2008-11-27 Mark Schmidt Method and System for Automatic Detection and Segmentation of Tumors and Associated Edema (Swelling) in Magnetic Resonance (Mri) Images
US20120280686A1 (en) * 2011-05-06 2012-11-08 The Regents Of The University Of California Measuring biological tissue parameters using diffusion magnetic resonance imaging

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130176026A1 (en) * 2012-01-11 2013-07-11 Schlumberger Technology Corporation Magnetic Resonance Imaging Methods
US10132894B2 (en) * 2012-01-11 2018-11-20 Schlumberger Technology Corporation Magnetic resonance imaging methods

Also Published As

Publication number Publication date
US20140270453A1 (en) 2014-09-18
US9378548B2 (en) 2016-06-28
US9953418B2 (en) 2018-04-24
WO2013082207A1 (en) 2013-06-06

Similar Documents

Publication Publication Date Title
US9953418B2 (en) T2 spectral analysis for myelin water imaging
Veraart et al. TE dependent Diffusion Imaging (TEdDI) distinguishes between compartmental T2 relaxation times
Lorio et al. Neurobiological origin of spurious brain morphological changes: A quantitative MRI study
Pan et al. Role of very high order and degree B0 shimming for spectroscopic imaging of the human brain at 7 tesla
Haast et al. Reproducibility and reliability of quantitative and weighted T1 and T2∗ mapping for myelin-based cortical parcellation at 7 Tesla
US9339239B2 (en) Methods and devices for optimization of magnetic resonance imaging protocols
O'callaghan et al. Tissue magnetic susceptibility mapping as a marker of tau pathology in Alzheimer's disease
Luo et al. Gradient echo plural contrast imaging—signal model and derived contrasts: T2*, T1, phase, SWI, T1f, FST2* and T2*-SWI
Budde et al. Ultra-high resolution imaging of the human brain using acquisition-weighted imaging at 9.4 T
Alonso‐Ortiz et al. Multi‐gradient‐echo myelin water fraction imaging: Comparison to the multi‐echo‐spin‐echo technique
Sun et al. Whole head quantitative susceptibility mapping using a least-norm direct dipole inversion method
US10613182B2 (en) MRI method to quantify iron amount in tissues using diffusion magnetic resonance imaging
Tardif et al. Regional impact of field strength on voxel‐based morphometry results
Meineke et al. Data consistency‐driven determination of‐fluctuations in gradient‐echo MRI
Zhang et al. MK-curve-Characterizing the relation between mean kurtosis and alterations in the diffusion MRI signal
Okada et al. Repeatability of proton magnetic resonance spectroscopy of the brain at 7 T: effect of scan time on semi-localized by adiabatic selective refocusing and short-echo time stimulated echo acquisition mode scans and their comparison
Chou et al. Effects of b-value and echo time on magnetic resonance diffusion tensor imaging-derived parameters at 1.5 T: a voxel-wise study
Cheng et al. Diffusion tensor imaging with cerebrospinal fluid suppression and signal-to-noise preservation using acquisition combining fluid-attenuated inversion recovery and conventional imaging: comparison of fiber tracking
Kosior et al. Algebraic T2 estimation improves detection of right temporal lobe epilepsy by MR T2 relaxometry
Mathiesen et al. Multi‐slice echo‐planar spectroscopic MR imaging provides both global and local metabolite measures in multiple sclerosis
US11857306B1 (en) Concurrent MRSI and fMRI
Guo et al. T 2 spectral analysis for myelin water imaging
Griffanti et al. Signal-to-noise ratio of diffusion weighted magnetic resonance imaging: Estimation methods and in vivo application to spinal cord
Petr et al. Improving arterial spin labeling data by temporal filtering
US20210356542A1 (en) Method and system for mapping transverse relaxation in magnetic resonance scan

Legal Events

Date Code Title Description
AS Assignment

Owner name: ST. JUDE CHILDREN'S RESEARCH HOSPITAL, TENNESSEE

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GUO, JUNYU;REDDICK, WILBURN E.;REEL/FRAME:038734/0734

Effective date: 20140519

STCF Information on status: patent grant

Free format text: PATENTED CASE

CC Certificate of correction
MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

Year of fee payment: 4